PERSPECTIVE: SOME CONCLUSIONS FROM MY LIFE IN HEALTH TECHNOLOGY ASSESSMENT
- PMID: 29609663
- DOI: 10.1017/S0266462318000107
PERSPECTIVE: SOME CONCLUSIONS FROM MY LIFE IN HEALTH TECHNOLOGY ASSESSMENT
Abstract
I have worked in health technology assessment (HTA) since 1975, beginning in the United States Congress Office of Technology Assessment (OTA), where we were charged with defining "medical technology assessment". My main concern in HTA has always been efficacy of healthcare interventions. After years in OTA, I was invited to the Netherlands in 1985, where the Dutch government invited me to head a special commission concerning future healthcare technology and HTA. From there, I became involved in over forty countries, beginning in Europe and then throughout the world. My most intense involvements, outside the United States and Europe, have been in Brazil, China, and Malaysia. During these 40-plus years, I have seen HTA grow from its earliest beginnings to a worldwide force for better health care for everyone. I have also had some growing concerns, outlined in this Perspective article. Within HTA, I am most disappointed by a narrow perspective of cost-effective analysis, which tends to ignore considerations of culture, society, ethics, and organizational and legal issues. In the general environment affecting HTA and health care, I am most concerned about the need to protect the independence of HTA activities from influences of the healthcare industries.
Keywords: HTA; History of HTA.
Similar articles
-
Health technology assessment: research trends and future priorities in Europe.J Health Serv Res Policy. 2011 Jul;16 Suppl 2:6-15. doi: 10.1258/jhsrp.2011.011050. J Health Serv Res Policy. 2011. PMID: 21737525
-
CHALLENGES IN CONTEMPORARY HEALTH TECHNOLOGY ASSESSMENT: A VIEW FROM THE OUTSIDE.Int J Technol Assess Health Care. 2016 Jan;32(1-2):1-2. doi: 10.1017/S0266462316000143. Epub 2016 Apr 11. Int J Technol Assess Health Care. 2016. PMID: 27064102
-
The development of health technology assessment.Health Policy. 2003 Feb;63(2):121-32. doi: 10.1016/s0168-8510(02)00059-3. Health Policy. 2003. PMID: 12543525
-
Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.Value Health. 2017 Apr;20(4):520-532. doi: 10.1016/j.jval.2016.12.003. Epub 2017 Jan 27. Value Health. 2017. PMID: 28407993 Review.
-
Health technology assessment of medical devices: What is different? An overview of three European projects.Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):309-18. doi: 10.1016/j.zefq.2015.06.011. Epub 2015 Jul 26. Z Evid Fortbild Qual Gesundhwes. 2015. PMID: 26354131 Review.
Cited by
-
Bibliometric Analysis of Health Technology Research: 1990~2020.Int J Environ Res Public Health. 2022 Jul 25;19(15):9044. doi: 10.3390/ijerph19159044. Int J Environ Res Public Health. 2022. PMID: 35897415 Free PMC article.
-
Finance, data and technology initiatives for noncommunicable disease control.Bull World Health Organ. 2019 Feb 1;97(2):166-168. doi: 10.2471/BLT.18.220558. Epub 2018 Dec 21. Bull World Health Organ. 2019. PMID: 30728624 Free PMC article. No abstract available.
-
HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?Eur J Health Econ. 2020 Feb;21(1):1-5. doi: 10.1007/s10198-019-01103-9. Eur J Health Econ. 2020. PMID: 31440857 No abstract available.
-
Genuine policy learning is fundamental: the journey of the United Arab Emirates toward the establishment of health technology assessment.Int J Technol Assess Health Care. 2023 Jan 9;39(1):e3. doi: 10.1017/S0266462322003348. Int J Technol Assess Health Care. 2023. PMID: 36621844 Free PMC article.
-
Health technology assessment for pharmaceutical regulation in the European Union: do we need another body?J R Soc Med. 2020 Jan;113(1):12-15. doi: 10.1177/0141076819888618. Epub 2019 Nov 15. J R Soc Med. 2020. PMID: 31730419 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources